Glenmark Pharmaceuticals has executed a Business Transfer Agreement for the transfer of its Consumer Care Business to Glenmark Consumer Care Limited, a wholly owned subsidiary. The execution took place on September 15, 2025. The transaction is expected to be completed on or before December 31, 2025, subject to the fulfillment of customary conditions.
Consumer Care Business Transfer
Glenmark Pharmaceuticals has officially announced the execution of a Business Transfer Agreement concerning its Consumer Care Business. The agreement facilitates the transfer to Glenmark Consumer Care Limited, a subsidiary wholly owned by Glenmark Pharmaceuticals.
Key Dates
The Business Transfer Agreement was executed on September 15, 2025. This follows an earlier intimation dated August 14, 2025. The company anticipates the completion of the transaction on or before December 31, 2025. However, the completion is contingent upon the satisfaction of certain customary conditions.
Source: BSE
